SCHWARTZ ALICE N
Known title: DirectorCIK: 0001248076
Associated companies
Transaction History
| BIO | ▼ Sell | Gift | 3,190 | $0 | 8/26/2024 | View on chart |
| BIO | ▼ Sell | Gift | 342 | $0 | 8/26/2024 | View on chart |
| BIO | ▼ Sell | Gift | 3,270 | $0 | 12/5/2023 | View on chart |
| BIO | ▼ Sell | Gift | 294 | $0 | 12/5/2023 | View on chart |
| BIO | ▼ Sell | Gift | 2,639 | $0 | 11/7/2022 | View on chart |
| BIO | ▼ Sell | Gift | 252 | $0 | 11/7/2022 | View on chart |
| BIO | ▼ Sell | Gift | 1,366 | $0 | 11/9/2021 | View on chart |
| BIO | ▼ Sell | Gift | 120 | $0 | 11/9/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.